Amprenavir: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Newer edit →
David Canner (talk | contribs)
7,699 edits
New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Amprenavir, better known as Aptivus, (2o4p)"/> ===Better Known as: === * Marketed By: Gla...
 
David Canner (talk | contribs)
7,699 edits
No edit summary
Line 1: Line 1:
<applet  load="" size="480" color="" frame="true"  spin="on" Scene ="" align="right" caption="Amprenavir, better known as Aptivus, ([[2o4p]])"/>
<applet  load="" size="480" color="" frame="true"  spin="on" Scene ="" align="right" caption="Amprenavir, better known as Agenerase, ([[2o4p]])"/>
===Better Known as: ===
===Better Known as: Agenerase===
* Marketed By: GlaxoSmithKline<br />
* Marketed By: GlaxoSmithKline<br />
* Major Indication: [[Human Immunodeficiency Virus]] Infection<br />
* Major Indication: [[Human Immunodeficiency Virus]] Infection<br />
Line 6: Line 6:
* Date of FDA Approval (Discontinued): 1999 (2004) <br />
* Date of FDA Approval (Discontinued): 1999 (2004) <br />
* 2009 Sales: N/A
* 2009 Sales: N/A
* Importance: It was the ninth [[HIV Protease]] inhibitor approved by the FDA for treatment of HIV. It is a very potent inhibitor, and is often recommended for patients who have become resistant to other treatments, but also has a relatively harsh side-effect profile.  
* Importance: It was the first [[HIV Protease]] inhibitor which required only twice-a-day dosing as opposed to every 8 hours. It was replaced by a longer acting prodrug version called [[Fosamprenavir]].
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information


Retrieved from "https://proteopedia.org/Amprenavir"